Alfredo José Lucendo Villarín-rekin lankidetzan egindako argitalpenak (5)

2022

  1. Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

    United European Gastroenterology Journal, Vol. 10, Núm. 5, pp. 507-517

  2. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme

    United European gastroenterology journal, Vol. 10, Núm. 3, pp. 330-343

  3. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe

    Therapeutic Advances in Gastroenterology, Vol. 15

2020

  1. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

    Gastroenterology, Vol. 159, Núm. 5, pp. 1672-1685.e5

2019

  1. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Gastroenterology, Vol. 157, Núm. 1, pp. 74-86.e15